The main goals of the meeting are to get FDA feedback on relevant chemistry, manufacturing & controls, alignment on potency assays for commercial product release, and the company's proposed design and primary endpoint for the confirmatory trial, it said.

http://www.mtnewswires.com
Copyright © 2025 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.